Additional Topics:
Allergy and Immunology
-
Scientific Symposia at ATS 2025 Examine New Results from Longitudinal Studies in Asthma
on
Read more: Scientific Symposia at ATS 2025 Examine New Results from Longitudinal Studies in AsthmaThe Allergy, Immunology, and Inflammation (All) Assembly has curated a robust lineup of educational opportunities at the ATS 2025 International Conference for professionals interested in exploring recent developments and the future of asthma management. All Assembly leaders Yvonne Huang, MD, ATSF, and Rachel Scheraga, MD, ATSF, spotlight some of the most anticipated sessions at this…
-
Symposia Spotlight Machine Learning and Artificial Intelligence Applications for Allergy, Immunology, and Inflammation Specialists
on
Read more: Symposia Spotlight Machine Learning and Artificial Intelligence Applications for Allergy, Immunology, and Inflammation SpecialistsArtificial intelligence and machine learning have become hot topics across many industries, including health care. The All Assembly has curated several opportunities to explore the mechanisms and applications of these technologies. Drs. Scheraga and Huang previewed several of these cutting-edge educational sessions at ATS 2025 with ATS Conference News.
Bronchiectasis and COPD
-
Explore the Latest Research and Clinical Guidelines for Bronchiectasis at ATS 2025
on
Read more: Explore the Latest Research and Clinical Guidelines for Bronchiectasis at ATS 2025Despite the complexities of managing and treating bronchiectasis, recent research developments provide reasons for optimism. The FDA has set Aug. 12 as an action date for its review of brensocatib, which has the potential to be the first FDA-approved medication for bronchiectasis. Dan Belz, MD, MPH, spoke with ATS Conference News about how these developments,…
-
ATS 2025 Program Tackles Advancements and Pressing Challenges with COPD
on
Read more: ATS 2025 Program Tackles Advancements and Pressing Challenges with COPDAccording to the World Health Organization, chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death globally, accounting for approximately five percent of deaths worldwide in 2021. The ATS International Conference is a rare opportunity for health specialists from around the globe to share insights and collectively address the most prevalent challenges in…
-
Bronchiectasis and COPD Lineup at ATS 2025
on
Read more: Bronchiectasis and COPD Lineup at ATS 2025The ATS 2025 International Conference offers a robust scientific program featuring several scientific symposia, abstract presentations, and Meet the Expert sessions addressing the latest investigative findings and clinical insights for bronchiectasis and COPD.